185 related articles for article (PubMed ID: 23302226)
1. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
[TBL] [Abstract][Full Text] [Related]
2. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
3. Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours.
Armstrong JL; Veal GJ; Redfern CP; Lovat PE
Apoptosis; 2007 Mar; 12(3):613-22. PubMed ID: 17216584
[TBL] [Abstract][Full Text] [Related]
4. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
Grande L; Bretones G; Rosa-Garrido M; Garrido-Martin EM; Hernandez T; Fraile S; Botella L; de Alava E; Vidal A; Garcia del Muro X; Villanueva A; Delgado MD; Fernandez-Luna JL
J Biol Chem; 2012 Aug; 287(32):26495-505. PubMed ID: 22718761
[TBL] [Abstract][Full Text] [Related]
5. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
[TBL] [Abstract][Full Text] [Related]
7. Noxa induces apoptosis in oncogene-expressing cells through catch-and-release mechanism operating between Puma and Mcl-1.
Nakajima W; Tanaka N
Biochem Biophys Res Commun; 2011 Oct; 413(4):643-8. PubMed ID: 21945433
[TBL] [Abstract][Full Text] [Related]
8. Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines.
Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
Int J Cancer; 1997 Nov; 73(4):592-9. PubMed ID: 9389577
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
10. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma.
Kerley-Hamilton JS; Pike AM; Li N; DiRenzo J; Spinella MJ
Oncogene; 2005 Sep; 24(40):6090-100. PubMed ID: 15940259
[TBL] [Abstract][Full Text] [Related]
11. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
12. APAF-1 is related to an undifferentiated state in the testicular germ cell tumor pathway.
Behjati R; Kawai K; Inadome Y; Kano J; Akaza H; Noguchi M
Cancer Sci; 2011 Jan; 102(1):267-74. PubMed ID: 20977544
[TBL] [Abstract][Full Text] [Related]
13. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation.
Kutuk O; Arisan ED; Tezil T; Shoshan MC; Basaga H
Carcinogenesis; 2009 Sep; 30(9):1517-27. PubMed ID: 19578044
[TBL] [Abstract][Full Text] [Related]
15. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
Gutekunst M; Oren M; Weilbacher A; Dengler MA; Markwardt C; Thomale J; Aulitzky WE; van der Kuip H
PLoS One; 2011 Apr; 6(4):e19198. PubMed ID: 21532991
[TBL] [Abstract][Full Text] [Related]
16. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles.
Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G
Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579
[TBL] [Abstract][Full Text] [Related]
17. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms.
Palumbo C; van Roozendaal K; Gillis AJ; van Gurp RH; de Munnik H; Oosterhuis JW; van Zoelen EJ; Looijenga LH
J Pathol; 2002 Apr; 196(4):467-77. PubMed ID: 11920744
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines.
Burger H; Nooter K; Boersma AW; Kortland CJ; Stoter G
Br J Cancer; 1998 May; 77(10):1562-7. PubMed ID: 9635829
[TBL] [Abstract][Full Text] [Related]
19. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells.
Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X
Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791
[TBL] [Abstract][Full Text] [Related]
20. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells.
Sharma K; Vu TT; Cook W; Naseri M; Zhan K; Nakajima W; Harada H
Mol Oncol; 2018 Jun; 12(6):788-798. PubMed ID: 29352505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
